81 related articles for article (PubMed ID: 6538115)
1. Enhancement of cisplatin nephrotoxicity by probenecid.
Daley-Yates PT; McBrien DC
Cancer Treat Rep; 1984 Feb; 68(2):445-6. PubMed ID: 6538115
[No Abstract] [Full Text] [Related]
2. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
Capizzi RL
Semin Oncol; 1999 Apr; 26(2 Suppl 7):72-81. PubMed ID: 10348264
[TBL] [Abstract][Full Text] [Related]
3. [Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity].
Takayama K; Nakanishi Y; Takano K; Harada T; Inoue K; Osaki S; Minami T; Hara N
Gan To Kagaku Ryoho; 1999 Mar; 26(4):503-8. PubMed ID: 10097747
[TBL] [Abstract][Full Text] [Related]
4. [Drug nephrotoxicity].
Nihon Jinzo Gakkai Shi; 1986 Jul; 28(7):929-46. PubMed ID: 3795607
[No Abstract] [Full Text] [Related]
5. Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
Ahn JH; Kang YK; Kim TW; Bahng H; Chang HM; Kang WC; Kim WK; Lee JS; Park JS
Cancer Chemother Pharmacol; 2002 Aug; 50(2):104-10. PubMed ID: 12172973
[TBL] [Abstract][Full Text] [Related]
6. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced nephrotoxicity.
Meijer S; Sleijfer DT; Mulder NH; Donker AJ
Neth J Med; 1982; 25(8):262-9. PubMed ID: 6755283
[No Abstract] [Full Text] [Related]
10. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients.
Hu YJ; Chen Y; Zhang YQ; Zhou MZ; Song XM; Zhang BZ; Luo L; Xu PM; Zhao YN; Zhao YB; Cheng G
Biol Trace Elem Res; 1997 Mar; 56(3):331-41. PubMed ID: 9197929
[TBL] [Abstract][Full Text] [Related]
11. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
Benoehr P; Krueth P; Bokemeyer C; Grenz A; Osswald H; Hartmann JT
J Am Soc Nephrol; 2005 Feb; 16(2):452-8. PubMed ID: 15590762
[TBL] [Abstract][Full Text] [Related]
12. [Urinary lysozyme, beta-2-microglobulin, and alpha-glucosidase during cisplatin therapy].
Airoldi M; Pecchio F; Albanese F; Mastromatteo V; Gariboldi A; Di Costanzo G; Fazio M
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):392-8. PubMed ID: 9704142
[No Abstract] [Full Text] [Related]
13. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
[TBL] [Abstract][Full Text] [Related]
14. [New frontiers in cancer chemotherapy: cis-platinum].
Sulkes A; Peretz T; Rizel S; Yahalom Y; Brian S
Harefuah; 1986 Jan; 110(2):90-3. PubMed ID: 3516812
[No Abstract] [Full Text] [Related]
15. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of cisplatin-induced nephrotoxicity by methionine.
Alden WW; Repta AJ
Chem Biol Interact; 1984 Jan; 48(1):121-4. PubMed ID: 6537905
[No Abstract] [Full Text] [Related]
17. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.
Sastry J; Kellie SJ
Pediatr Hematol Oncol; 2005; 22(5):441-5. PubMed ID: 16020136
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, a new antineoplastic drug in veterinary medicine.
Page R; Matus RE; Leifer CE; Loar A
J Am Vet Med Assoc; 1985 Feb; 186(3):288-90. PubMed ID: 3918977
[No Abstract] [Full Text] [Related]
19. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats.
Borrego A; Zamora ZB; González R; Romay C; Menéndez S; Hernández F; Montero T; Rojas E
Mediators Inflamm; 2004 Feb; 13(1):13-9. PubMed ID: 15203559
[TBL] [Abstract][Full Text] [Related]
20. Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
Cronin S; Uberti JP; Ayash LJ; Raith C; Ratanatharathorn V
Bone Marrow Transplant; 2000 Dec; 26(11):1247-9. PubMed ID: 11149742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]